MedPath

Prebiotic effect in patients with type 2 diabetes.

Phase 2
Conditions
Type 2 Diabetes.
Diabetes mellitus due to underlying condition
Registration Number
IRCT2016122720965N2
Lead Sponsor
Vice chancellor for reserach, Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
80
Inclusion Criteria

Having type 2 diabetes for more than six months according International Diabetes Federation (fasting blood sugar level more than 126 mg/dl)
Using anti-diabetic drugs and maintaining them in the period of the study
Having a normal diet and Body Mass Index (BMI) more than 25 kg/m2 in the last 3 months

Exclusion Criteria

Having history of gastrointestinal; cardiovascular; renal; thyroid; liver; or pancreatic diseases
Pregnancy and lactating
Smokers
Consuming prebiotic and probiotics’ products
Consuming antibiotics; antiacids; alcohol; anti-diarrheal; anti-inflammatory; lipid-lowering; laxatives or insulin
Having a typical fiber intake more than 30g/d.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath